VanEck Associates’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $364K | Sell |
4,268
-1,268
| -23% | -$113K | ﹤0.01% | 1215 |
|
|
2025
Q4 | $437K | Buy |
5,536
+506
| +10% | +$39.7K | ﹤0.01% | 1193 |
|
|
2025
Q3 | $402K | Buy |
5,030
+3,564
| +243% | +$304K | ﹤0.01% | 1213 |
|
|
2025
Q2 | $133K | Hold |
1,466
| – | – | ﹤0.01% | 1285 |
|
|
2025
Q1 | $137K | Hold |
1,466
| – | – | ﹤0.01% | 1257 |
|
|
2024
Q4 | $133K | Sell |
1,466
-35,344
| -96% | -$3.37M | ﹤0.01% | 1259 |
|
|
2024
Q3 | $3.64M | Sell |
36,810
-3,677
| -9% | -$375K | ﹤0.01% | 760 |
|
|
2024
Q2 | $3.93M | Buy |
40,487
+1,940
| +5% | +$179K | 0.01% | 667 |
|
|
2024
Q1 | $3.47M | Sell |
38,547
-8,693
| -18% | -$737K | 0.01% | 701 |
|
|
2023
Q4 | $3.77M | Sell |
47,240
-2,247
| -5% | -$169K | 0.01% | 626 |
|
|
2023
Q3 | $3.52M | Buy |
49,487
+2,139
| +5% | +$160K | 0.01% | 600 |
|
|
2023
Q2 | $3.65M | Sell |
47,348
-171
| -0.4% | -$13.2K | 0.01% | 586 |
|
|
2023
Q1 | $3.57M | Buy |
47,519
+17,450
| +58% | +$1.3M | 0.01% | 563 |
|
|
2022
Q4 | $2.37M | Buy |
30,069
+956
| +3% | +$71.7K | 0.01% | 642 |
|
|
2022
Q3 | $2.04M | Sell |
29,113
-8,138
| -22% | -$638K | 0.01% | 639 |
|
|
2022
Q2 | $2.98M | Sell |
37,251
-75,064
| -67% | -$5.87M | 0.01% | 579 |
|
|
2022
Q1 | $8.52M | Sell |
112,315
-4,326
| -4% | -$343K | 0.02% | 395 |
|
|
2021
Q4 | $9.96M | Buy |
116,641
+101,728
| +682% | +$7.94M | 0.02% | 374 |
|
|
2021
Q3 | $1.13M | Buy |
14,913
+591
| +4% | +$46.9K | ﹤0.01% | 787 |
|
|
2021
Q2 | $1.17M | Sell |
14,322
-1,304
| -8% | -$107K | ﹤0.01% | 777 |
|
|
2021
Q1 | $1.23M | Sell |
15,626
-12,815
| -45% | -$1M | ﹤0.01% | 711 |
|
|
2020
Q4 | $2.43M | Buy |
28,441
+1,439
| +5% | +$119K | 0.01% | 507 |
|
|
2020
Q3 | $2.08M | Sell |
27,002
-27,292
| -50% | -$2.08M | 0.01% | 475 |
|
|
2020
Q2 | $3.98M | Sell |
54,294
-14,109
| -21% | -$1M | 0.01% | 367 |
|
|
2020
Q1 | $4.54M | Sell |
68,403
-22,665
| -25% | -$1.6M | 0.02% | 324 |
|
|
2019
Q4 | $6.27M | Buy |
91,068
+3,350
| +4% | +$228K | 0.02% | 337 |
|
|
2019
Q3 | $6.45M | Buy |
87,718
+4,550
| +5% | +$330K | 0.03% | 293 |
|
|
2019
Q2 | $5.96M | Buy |
83,168
+7,415
| +10% | +$526K | 0.03% | 292 |
|
|
2019
Q1 | $5.19M | Buy |
75,753
+2,669
| +4% | +$172K | 0.03% | 297 |
|
|
2018
Q4 | $4.35M | Sell |
73,084
-289,304
| -80% | -$18.1M | 0.02% | 325 |
|
|
2018
Q3 | $24.3M | Buy |
362,388
+16,775
| +5% | +$1.12M | 0.12% | 158 |
|
|
2018
Q2 | $22.4M | Buy |
+345,613
| New | +$22.6M | 0.1% | 164 |
|
|
2015
Q2 | – | Sell |
-2,804
| Closed | -$194K | – | 817 |
|
|
2015
Q1 | $194K | Buy |
2,804
+1,330
| +90% | +$91.9K | ﹤0.01% | 590 |
|
|
2014
Q4 | $102K | Buy |
+1,474
| New | +$99.5K | ﹤0.01% | 641 |
|
Other funds holding CL
VCM
DAM
VPM
VanEck Associates's CL Position: Q1 2026 in Review
VanEck Associates reduced its Colgate-Palmolive (CL) stake by 23% in Q1 2026, selling an estimated $113K and leaving 4,268 shares worth $364K. The position accounts for ﹤0.01% of the portfolio, ranked #1215.
VanEck Associates first reported a position in CL in Q4 2014 and has held it in 34 quarters since. The position peaked at $24.3M in Q3 2018. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.
- VanEck Associates held 4,268 shares of Colgate-Palmolive worth $364K as of Q1 2026.
- VanEck Associates sold 1,268 Colgate-Palmolive shares in Q1 2026, an estimated $113K.
- Colgate-Palmolive made up ﹤0.01% of VanEck Associates's portfolio in Q1 2026, its #1215 holding.
- VanEck Associates first reported a position in Colgate-Palmolive in Q4 2014 and has held it in 34 quarters since.
- VanEck Associates's Colgate-Palmolive position peaked at $24.3M in Q3 2018.
- 1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.
Based on VanEck Associates's 13F filing for Q1 2026, filed 15 May 2026.